PICHINI, SIMONA
 Distribuzione geografica
Continente #
NA - Nord America 2.378
EU - Europa 743
AS - Asia 108
OC - Oceania 5
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 3.239
Nazione #
US - Stati Uniti d'America 2.376
IT - Italia 170
IE - Irlanda 161
SE - Svezia 129
UA - Ucraina 103
DE - Germania 65
SG - Singapore 52
GB - Regno Unito 44
IN - India 30
FI - Finlandia 21
BE - Belgio 17
CN - Cina 10
AT - Austria 8
FR - Francia 7
DK - Danimarca 6
AU - Australia 5
TR - Turchia 5
JP - Giappone 4
PL - Polonia 4
CH - Svizzera 2
PH - Filippine 2
RU - Federazione Russa 2
TH - Thailandia 2
ZA - Sudafrica 2
CA - Canada 1
EU - Europa 1
IL - Israele 1
KR - Corea 1
LV - Lettonia 1
MT - Malta 1
MX - Messico 1
PE - Perù 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 3.239
Città #
Chandler 358
Des Moines 263
Fairfield 237
Jacksonville 182
Ashburn 168
Dublin 161
Wilmington 109
Houston 104
Woodbridge 101
Seattle 99
Cambridge 87
Lawrence 62
Princeton 62
San Mateo 51
Ann Arbor 49
New York 46
Turin 37
Boardman 32
Pune 22
San Diego 22
Helsinki 21
London 21
Washington 18
Rome 16
Brussels 11
Centro 11
Los Angeles 11
Falls Church 10
Milan 10
Kilburn 9
Norwalk 9
Vienna 8
Mohali 7
Jinan 6
Boydton 5
Beijing 4
Civitanova Marche 4
Hrebenne 4
Wandsworth 4
Ancona 3
Brisbane 3
Hounslow 3
Izmir 3
Messina 3
Redwood City 3
Tokyo 3
Adelaide 2
Agugliano 2
Ashville 2
Bangkok 2
Birmingham 2
Carisio 2
Chions 2
Copenhagen 2
Frankfurt Am Main 2
Frankfurt am Main 2
Islington 2
Istanbul 2
Legaspi Port 2
Marche 2
Modena 2
Montesilvano Marina 2
Perugia 2
Pesaro 2
Redmond 2
Aarhus 1
Atlanta 1
Chicago 1
Como 1
Eugene 1
Frederiksberg 1
Guadalajara 1
Hyderabad 1
Il-Madliena 1
Leningradskaya 1
Lima 1
Monsampolo del Tronto 1
Paris 1
Pavia 1
Portland 1
Prescot 1
Resana 1
Saint Louis 1
Santa Clara 1
Seregno 1
Southwark 1
Stockholm 1
Taipei 1
Tel Aviv 1
Tolentino 1
Vancouver 1
Totale 2.526
Nome #
THC and CBD concentrations in blood, oral fluid and urine following a single and repeated administration of "light cannabis" 91
Toxicology and analysis of psychoactive tryptamines 83
Stability and Degradation Pathways of Different Psychoactive Drugs in Neat and in Buffered Oral Fluid 79
European drug users at risk from illicit fentanyls mix 77
Maternal hair testing to disclose self-misreporting in drinking and smoking behavior during pregnancy 77
UHPLC-MS/MS analysis of cannabidiol metabolites in serum and urine samples. Application to an individual treated with medical cannabis 74
Disposition of cannabidiol metabolites in serum and urine from healthy individuals treated with pharmaceutical preparations of medical cannabis 72
Herbal preparations of medical cannabis: A vademecum for prescribing doctors 71
Monitoring Perinatal Exposure to Cannabis and Synthetic Cannabinoids 69
Measurement uncertainty in forensic toxicology 68
Monitoring Prenatal Exposure to Buprenorphine and Methadone 67
Cannabidiol adverse effects and toxicity 66
Disposition of cannabinoids and their metabolites in serum, oral fluid, sweat patch and urine from healthy individuals treated with pharmaceutical preparations of medical cannabis 66
Correspondence 63
Testing Unconventional Matrices to Monitor for Prenatal Exposure to Heroin, Cocaine, Amphetamines, Synthetic Cathinones, and Synthetic Opioids 63
Fast and sensitive UHPLC-MS/MS analysis of cannabinoids and their acid precursors in pharmaceutical preparations of medical cannabis and their metabolites in conventional and non-conventional biological matrices of treated individual 62
Ultra-high-performance liquid chromatography-tandem mass spectrometry assay for quantifying fentanyl and 22 analogs and metabolites in whole blood, urine, and hair 61
Dilute and shoot ultra-high performance liquid chromatography tandem mass spectrometry (UHPLC–MS/MS) analysis of psychoactive drugs in oral fluid 61
Commentary - Heroin purity and adulteration: An updated snapshot from the Italian Early Warning System 60
Development and validation of fast UHPLC-MS/MS screening method for 87 NPS and 32 other drugs of abuse in hair and nails: application to real cases 59
Determination of the synthetic cannabinoids JWH-122, JWH-210, UR-144 in oral fluid of consumers by GC-MS and quantification of parent compounds and metabolites by UHPLC-MS/MS 59
Δ9-Tetrahydrocannabinol and Cannabidiol Time Courses in the Sera of "Light Cannabis" Smokers: Discriminating Light Cannabis Use from Illegal and Medical Cannabis Use 58
A comprehensive HPLC–MS-MS screening method for 77 new psychoactive substances, 24 classic drugs and 18 related metabolites in blood, urine and oral fluid 58
Evaluation of long-term stability of cannabinoids in standardized preparations of cannabis flowering tops and cannabis oil by ultra-high-performance liquid chromatography tandem mass spectrometry 58
Acute Intoxications and Fatalities Associated with Benzimidazole Opioid (Nitazene Analog) Use: A Systematic Review 58
Analytical Strategies to Disclose Repeated Consumption of New Psychoactive Substances by Hair Analysis 55
Synthetic cathinones related fatalities: an update 55
Analytical advances in clinical and forensic toxicology. Second part 54
Pharmacology and legal status of cannabidiol 54
Acute Intoxications and Fatalities From Illicit Fentanyl and Analogues: An Update 53
Metabolic pathways and potencies of new fentanyl analogs 51
Advances and future developments in forensic toxicology: From standard practices to new psychoactive substances 49
Nails analysis for drugs used in the context of chemsex: A pilot study 49
Comment on "direct Monitoring of Exogenous γ-Hydroxybutyric Acid in Body Fluids by NMR Spectroscopy": Several Issues to Consider When Quantifying γ-Hydroxybutyric Acid in Biological Matrixes 49
Clarifying methodological issues in cannabinoids determination in bronchoalveolar lavages 48
Determination of cannabinoids in oral fluid and urine of "light cannabis" consumers: A pilot study 48
A fatal chemsex case involving γ-butyrolactone and 4-methylethcathinone 47
The importance of biomarkers of fetal exposure to alcohol and psychotropic drugs in early diagnosis: A case report 46
Editorial: The challenge posed by new synthetic opioids: Pharmacology and toxicology 43
Ultra-high-performance liquid chromatography tandem mass spectrometry assay for determination of endogenous ghb and ghb-glucuronide in nails 42
Cannabinoids determination in bronchoalveolar lavages of cannabis smokers with lung disease 42
UHPLC-MS/MS analysis of cannabidiol and its metabolites in serum of patients with resistant epilepsy treated with CBD formulations 42
Medicinal cannabis and synthetic cannabinoid use 41
Pharmacotoxicology of non-fentanyl derived new synthetic opioids 40
Stability of cannabinoids in cannabis FM1 flowering tops and oil preparation evaluated by ultra-high performance liquid chromatography tandem mass spectrometry 39
Editorial: Analytical Advances in Clinical and Forensic Toxicology 38
New psychoactive substances: A matter of time 38
Screening methods for rapid determination of new psychoactive substances (NPS) in conventional and non-conventional biological matrices 37
Cannabis: Neurological correlates in abuse and medical use 37
GHB concentration in breast milk of narcoleptic women treated with sodium oxybate. How important it is to be careful when interpreting values 37
Global prevalence of fetal alcohol spectrum disorder in Italy 37
Acute Pharmacological Effects and Oral Fluid Concentrations of the Synthetic Cannabinoids JWH-122 and JWH-210 in Humans After Self-Administration: An Observational Study 36
GHB side effects: The need to clearly document drug dose and administration history 35
Segmental hair testing of triazolam to unmask a suspected case of idiopathic recurrent Stupor 35
Acute pharmacological effects and oral fluid biomarkers of the synthetic cannabinoid ur-144 and thc in recreational users 34
Nails in Forensic Toxicology: an Update 33
The National Early Warning System, a web-based platform to prevent the spread of New Psychoactive Substances 33
The issue of psychotropic drug monitoring in sexual assault victims 32
The complex and constantly evolving public health threat of new psychoactive substances in Italy: Addressing the main functions of a national observatory of drugs 28
The value of toxicological and forensic analyses in the global challenge to health risks caused by new psychoactive substances 27
Herbal highs: Review on Psychoactive Effects and Neuropharmacology 26
Ultra-high-performance liquid chromatography-tandem mass spectrometry assay for quantifying THC, CBD and their metabolites in hair. Application to patients treated with medical cannabis 25
Methylone and MDMA Pharmacokinetics Following Controlled Administration in Humans 25
Molecular Insights on New Psychoactive Substances (NPSs) 18
Correlation between Blood and Oral Fluid Psychoactive Drug Concentrations and Cognitive Impairment in Driving under the Influence of Drugs 16
null 12
Pharmacological effects of methylone and MDMA in humans 12
Disposition of phytocannabinoids, their acidic precursors and their metabolites in biological matrices of healthy individuals treated with vaporized medical cannabis 9
Development of enantioselective high-performance liquid chromatography-tandem mass spectrometry method for quantitative determination of methylone and some of its metabolites in oral fluid 7
Sweat Testing for the Detection of Methylone after Controlled Administrations in Humans 5
Usefulness of Oral Fluid for Measurement of Methylone and Its Metabolites: Correlation with Plasma Drug Concentrations and the Effect of Oral Fluid pH 5
Liquid Chromatography High-Resolution Mass Spectrometry in Forensic Toxicology: What are the Specifics of Method Development, Validation and Quality Assurance for Comprehensive Screening Approaches? 5
The new synthetic benzimidazole opioid etonitazepipne: an emerging fatal harm and a challenge for laboratory medicine 5
null 5
GHB-facilitated sexual assaults: How to proper assess a single GHB exposure in hair 5
Synthetic Benzimidazole Opioids: The Emerging Health Challenge for European Drug Users 4
Recent challenges and trends in forensic analysis: Δ9-THC isomers pharmacology, toxicology and analysis 4
Erratum to Reduced prevalence of fetal exposure to alcohol in Italy: a nationwide survey American Journal of Obstetrics & Gynecology MFM. Volume 5, Issue 6, June 2023, 100944 4
Editorial: Drug-drug interactions in pharmacology 3
Targeted screening and quantification of synthetic cathinones and metabolites in hair by UHPLC-HRMS 3
A “special dose” of ethics in forensic toxicology 2
Disposition of Hexahydrocannabinol Epimers and Their Metabolites in Biological Matrices following a Single Administration of Smoked Hexahydrocannabinol: A Preliminary Study 1
Target Analysis of NPS in Oral Fluid 1
Optimization of enantioselective high-performance liquid chromatography-tandem mass spectrometry method for the quantitative determination of 3,4-methylenedioxy-methamphetamine (MDMA) and its phase-1 metabolites in human biological fluids 1
Hexahydrocannabinol Pharmacology, Toxicology, and Analysis: The First Evidence for a Recent New Psychoactive Substance 1
Analytical procedures and blood threshold values to ascertain driving in a stae of psycho-physical impairment from drugs abuse|Procedure analitiche e valori decisionali ematici per accertare la guida in stato di alterazione psicofisica da sostanze d'abuso 1
Molecular Insights of New Psychoactive Substances (NPS) 2.0 1
Totale 3.350
Categoria #
all - tutte 21.566
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.566


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201934 0 0 0 0 0 0 0 0 0 1 31 2
2019/2020202 10 1 0 1 27 7 38 8 35 0 20 55
2020/2021890 55 51 79 3 55 64 120 117 79 79 85 103
2021/2022467 39 61 19 7 4 46 4 30 49 38 60 110
2022/20231.198 97 130 85 79 49 343 16 69 226 3 82 19
2023/2024545 86 14 86 58 92 131 26 22 10 20 0 0
Totale 3.350